Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-05-20 | Paul C. Grint, M.D. has served as a member of our Board of Directors since November 2015. Dr. Grint received a B.S. in Medical Science from St. Mary’s Hospital in London and his medical degree from St. Bartholomew’s Hospital Medical College at the University of London. The Nominating and Corporate Governance Committee and the Board of Directors believe that Dr. Grint’s significant experience in leading biotechnology and pharmaceutical companies, as well his significant experience in drug development and in the biotechnology industry, qualifies him to serve on our Board of Directors. |
| 2017-07-24 | Dr. Grint received a B.S. in Medical Science from St. Marys Hospital in London and his medical degree from St. Bartholomews Hospital Medical College at the University of London. |
| 2018-11-09 | Dr. Grint received a B.S. in Medical Science from St. Mary’s Hospital in London and his medical degree from St. Bartholomew’s Hospital Medical College at the University of London. |
Data sourced from SEC filings. Last updated: 2025-10-12